

Scientists in Barcelona have discovered a simple test that could revolutionize how doctors treat colorectal cancer, helping match patients with treatments most likely to save their lives.

The breakthrough could expand life-saving immunotherapy options beyond the tiny 5% of patients who currently qualify.

Want to know more?